Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6617)
All Articles published online
|
Publishing Process of This Article
|
Apr 27, 2020 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Surgery
ISSN
1948-9366
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Au KP, Chok KSH. Mammalian target of rapamycin inhibitors after post-transplant hepatocellular carcinoma recurrence: Is it too late? World J Gastrointest Surg 2020; 12(4): 149-158 [PMID: 32426094 DOI: 10.4240/wjgs.v12.i4.149] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i4/149.htm |
| Number | Citing Articles |
| 1 |
Kin Pan Au, James Yan Yue Fung, Wing Chiu Dai, Albert Chi Yan Chan, Chung Mau Lo, Kenneth Siu Ho Chok. Verifying the Benefits of Radical Treatment in Posttransplant Hepatocellular Carcinoma Oligo‐recurrence: A Propensity Score Analysis. Liver Transplantation 2022; 28(1): 51 doi: 10.1002/lt.26251
|
| 2 |
Ina Y. Aneva , Solomon Habtemariam, Maciej Banach, Parames C. Sil , Kasturi Sarkar, Adeleh Sahebnasagh , Mohammad Amjad Kamal, Maryam Khayatkashani, Hamid Reza Khayat Kashani. Can We Use mTOR Inhibitors for COVID-19 Therapy?. Combinatorial Chemistry & High Throughput Screening 2022; 25(11): 1805 doi: 10.2174/1386207325666211130140923
|
| 3 |
Luckshi Rajendran, Tommy Ivanics, Marco PAW Claasen, Hala Muaddi, Gonzalo Sapisochin. The management of post-transplantation recurrence of hepatocellular carcinoma. Clinical and Molecular Hepatology 2022; 28(1): 1 doi: 10.3350/cmh.2021.0217
|
| 4 |
Kin-Pan Au, James Yan-Yue Fung, Wing-Chiu Dai, Albert Chi-Yan Chan, Chung-Mau Lo, Kenneth Siu-Ho Chok. Impact of Tumour Biology on Outcomes of Radical Therapy for Hepatocellular Carcinoma Oligo-Recurrence after Liver Transplantation. Journal of Clinical Medicine 2022; 11(15): 4389 doi: 10.3390/jcm11154389
|
| 5 |
Faiza Ahmed, Faiza Zakaria, Godsgift Enebong Nya, Mohamad Mouchli. Sirolimus <i>vs</i> tacrolimus: Which one is the best therapeutic option for patients undergoing liver transplantation for hepatocellular carcinoma?. World Journal of Gastrointestinal Surgery 2022; 14(8): 862-866 doi: 10.4240/wjgs.v14.i8.862
|
| 6 |
Sezai Yilmaz, Volkan Ince. The Importance of the Immunosuppressive Regime on Hepatocellular Carcinoma Recurrence After Liver Transplantation. Journal of Gastrointestinal Cancer 2021; 52(4): 1350 doi: 10.1007/s12029-021-00716-9
|
| 7 |
Kin Pan Au, Kenneth Siu Ho Chok. Immunotherapy after liver transplantation: Where are we now?. World Journal of Gastrointestinal Surgery 2021; 13(10): 1266 doi: 10.4240/wjgs.v13.i10.1266
|
| 8 |
Ishfaq Hassan Mir, Shreyoshi Guha, Jajnasenee Behera, Chinnasamy Thirunavukkarasu. Targeting molecular signal transduction pathways in hepatocellular carcinoma and its implications for cancer therapy. Cell Biology International 2021; 45(11): 2161 doi: 10.1002/cbin.11670
|
| 9 |
Kin Pan Au, Kenneth Siu Ho Chok. Immunotherapy after liver transplantation: Where are we now?. World Journal of Gastrointestinal Surgery 2021; 13(10): 1267-1278 doi: 10.4240/wjgs.v13.i10.1267
|
| 10 |
Xiangyu Yan, Songhan Huang, Yang Yang, Ziwen Lu, Feiyu Li, Liyong Jiang, Yong Jiang, Jun Liu. Sirolimus or Everolimus Improves Survival After Liver Transplantation for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis. Liver Transplantation 2022; 28(6): 1063 doi: 10.1002/lt.26387
|
| 11 |
Kin-Pan Au, Wing-Chiu Dai, Albert Chi-Yan Chan, Tan-To Cheung, Chung-Mau Lo, Kenneth Siu-Ho Chok. Performance of Dual-tracer PET-CT for Staging Post–Liver Transplant Hepatocellular Carcinoma Recurrence. Transplantation Direct 2021; 7(10): e769 doi: 10.1097/TXD.0000000000001213
|